Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 5, 1996, Pages 841-846

  Anton, Raymond F ^a,b   Moak, Darlene H ^a   Latham, Patricia ^a  

^a MUSC Center for Drug and Alcohol Programs   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; CDT; GGT; Markers; Treatment

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; TRANSFERRIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENCE RISK; TRANSFERRIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0029834688     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb05261.x     Document Type: Article

References (27)

1. Stibler H: Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037, 1991
2. Mihas AA, Tavassoli M: Laboratory markers of ethanol intake and abuse: A critical appraisal. Am J Med Sci 303:415-428, 1992
3. Allen JP, Litten RZ, Anton RF, Cross GM: Carbohydrate-deficient transferrin as a measure of immoderate drinking: Remaining issues. Alcohol Clin Exp Res 18:799-812, 1994
4. Anton RF, Moak DH: Carbohydrate-deficient transferrin and γ-glutamyl transferase as markers of heavy alcohol consumption: Gender differences. Alcohol Clin Exp Res 18:747-754, 1994
5. Litten RZ, Allen JP, Fertig JB: Gamma-glutamyl transpeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption. Alcohol Clin Exp Res 19:1541-1546, 1995
6. Anton RF, Adinoff B, Moak D: A longitudinal evaluation of carbohydrate deficient transferrin (CDT) and gamma-glutamyl transferase in recently abstinent alcoholics. Alcohol Clin Exp Res 18:24A, 1994
7. Hultberg B, Isaksson A, Berglund M, Alling C: Increases and time-course variations in β-hexosaminidase isoenzyme B and carbohydrate-deficient transferrin in serum from alcoholics are similar. Alcohol Clin Exp Res 19:452-456, 1995
8. Salmela KS, Laitinen K, Nystrom M, Salaspuro M: Carbohydrate-deficient transferrin during 3 weeks' heavy alcohol consumption. Alcohol Clin Exp Res 18:228-230, 1994
9. Carlsson AV, Hiltunen AJ, Beck O, Stibler H, Borg S: Detection of relapses in alcohol-dependent patients: Comparison of carbohydrate-deficient transferrin in serum, 5-hydroxytryptophol in urine, and self-reports. Alcohol Clin Exp Res 17:703-708, 1993
10. Borg S, Helander A, Carlsson AV, A-M Hogstrom Brandt: Detection of relapses in alcohol-dependent patients using carbohydrate-deficient transferrin: Improvement with individualized reference levels during long-term monitoring. Alcohol Clin Exp Res 19:961-963, 1995
11. Rosman AS, Basu P, Galvin K, Lieber CS: Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients. Alcohol Clin Exp Res 19:611-616, 1995
12. Allen JP, Litten RZ, Anton R: Measures of alcohol consumption in perspective, in Litten RZ, Allen JP (eds): Measuring Alcohol Consumption. Totowa, NJ, Humana Press, 1992, pp 205-226
13. Anton RF, Litten RZ, Allen JP: Biological assessment of alcohol consumption, in Treatment Handbook Series 4: Assessing Alcohol Problems: A Guide for Clinicians and Researchers. NIH Publication 94-030. Bethesda, MD, NIH, 1996
14. Irwin M, Baird S, Smith TL, Schuckit M: Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. Am J Psychiatry 145:595-599, 1988
15. Chick J, Lloyd G, Crombie E: Counseling drinkers in medical wards: A controlled study. Br Med J 290:965-967, 1985
16. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
17. McLellan AT, Luborsky L, Woody GE, O'Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Nerv Mental Dis 168:26-33, 1980
18. Skinner HA, Allen BA: Alcohol dependence syndrome: Measurement and validation. Abnorm Psych 91:199-209, 1982
19. Sobell LC, Sobell MB, Leo CI, Cancilla A: Reliability of a timeline method. Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83:393-402, 1988
20. Stibler H, Borg S, Joustra M: A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Alcohol Suppl 1:451-454, 1991
21. Anton R, Bean P: Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin Chem 40:364-368, 1994
22. Fuller RK, Branchey L, Brightwell DR, Derman RM: Disulfiram treatment of alcoholism. JAMA 256:1449-1489, 1986
23. Dorus W, Ostrow DG, Anton RF, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, Willenbring M, Fiscella R, Sather MR: Lithium treatment of depressed and nondepressed alcoholics. JAMA 26:1646-1652, 1989
24. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881-887, 1992
25. Fuller RK, Lee KK, Gordis E: Validity of self-report in alcoholism research: Results of a Veterans Administration Cooperative Study. Alcohol Clin Exp Res 12:201-205, 1988
26. Kranzler HR, Mason BJ, Pettinati H, Anton RF: Methodological issues in clinical trials with alcoholics, in Hertzman M, Feltner D (eds): Clinical Trials of CNS Drugs. New York, New York University Press (in press), 1996
27. Lof K, Seppa K, Itala L, Koivula T, Turpeinen U, Sillanaukee P: Carbohydrate-deficient transferrin as an alcohol marker among female heavy drinkers: A population-based study. Alcohol Clin Exp Res 18:889-894, 1994